Evidence map›Paper›PMID 32524419›Full record

ReviewJournal of molecular neuroscience : MN2020

Genotype and Phenotype Correlations for TBL1XR1 in Neurodevelopmental Disorders.

Yingting Quan, Qiumeng Zhang, Meilin Chen, Huidan Wu, Jianjun Ou, Yidong Shen, Kuokuo Li, Guanglei Xun, Jingping Zhao, Zhengmao Hu and 2 more

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Journal of molecular neuroscience : MN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yingting QuanCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Qiumeng ZhangCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Meilin ChenCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Huidan WuCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Jianjun OuMental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yidong ShenMental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Kuokuo LiCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Guanglei XunMental Health Center of Shandong Province, Jinan, Shandong, China.
Jingping ZhaoMental Health Institute of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhengmao HuCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Kun XiaCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Hui GuoCenter for Medical Genetics & Hunan Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China. guohui@sklmg.edu.cn.ORCID https://orcid.org/0000-0002-1570-2545
Central South University · CNShandong Mental Health Center · CN

Funding

China Hunan Provincial Science & Technology Department 2019RS2005Innovation-Driven Project of Central South University 2020CX042National Natural Science Foundation of China 81330027National Natural Science Foundation of China 81525007
6 · The paper itself

Abstract

TBL1XR1 is a member of the WD40 repeat-containing gene family. Mutations of TBL1XR1 have been reported in neurodevelopmental disorders (NDDs). Although the phenotypes of some patients have been described in single studies, few studies have reviewed the genotype and phenotype relationships using a relatively large cohort of patients with TBL1XR1 mutations. Herein, we report a new de novo frameshift mutation in TBL1XR1 (NM_024665.4, c.388_389delAC, p.T130Sfs*14) in a patient with autism spectrum disorder (ASD). To explore the correlations between genotypes and phenotypes for TBL1XR1 in NDDs, we manually curated and analyzed 38 variants and the associated phenotypes from 50 individuals with NDDs. TBL1XR1 mutations lead to a wide range of phenotypic defects. We conclude that the most common phenotypes associated with TBL1XR1 mutations were language and motor developmental delay, intellectual disabilities, facial deformity, hypotonia, and microcephaly. Our study provides a comprehensive spectrum of neurodevelopmental phenotypes caused by TBL1XR1 mutations, which is important for genetic diagnosis and precision clinical management.

Indexed as

PhenotypeAutism Spectrum DisorderChildFrameshift MutationGenotypeHumansMaleReceptors, Cytoplasmic and NuclearRepressor ProteinsReceptors, Cytoplasmic and NuclearRepressor ProteinsTBL1XR1 protein, humanAutism spectrum disorderDe novo mutationGenotype-phenotype correlationNeurodevelopmental disorderTBL1XR1

Identifiers

PMID32524419
OpenAlexW3033819997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.